Table 4.
Serum levels of ProBNP (pg/ml) -bezafibrate vs placebo-
|
Bezafibrate (n = 58) |
Placebo (n = 50) |
|
| Baseline | ||
| Geometric mean (95% CI) | 154 (118–202) | 219 (168–284) |
| Median (Interquartile range) | 151 (89–335) | 215 (101–468) |
| Mean ± SD | 254 ± 295 | 331 ± 326 |
| P = 0.07 (t-test for ln-transformed values) | ||
| P = 0.11 (Kruskal-Wallis test) | ||
| 2-year follow-up | ||
| Geometric mean (95% CI) | 206 (157–271) | 209 (150–292) |
| Median (Interquartile range) | 230 (100–348) | 224 (82–503) |
| Mean ± SD | 374 ± 552 | 389 ± 442 |
| P = 0.95 (t-test for ln-transformed values) | ||
| P = 0.85 (Kruskal-Wallis test) | ||